LABORATORIO FARMAC.ERFO Market Cap ($8.69 Million)
Market Cap & Net Worth: LABORATORIO FARMAC.ERFO (RK7)
LABORATORIO FARMAC.ERFO market cap. LABORATORIO FARMAC.ERFO (F:RK7) has a market capitalization of $8.69 Million (€7.43 Million) as of November 4, 2026. Listed on the F stock exchange, this Germany-based company holds position #27303 globally and #2331 in its home market, demonstrating a 0.46% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying LABORATORIO FARMAC.ERFO's stock price €0.87 by its total outstanding shares 8520000 (8.52 Million). Also see LABORATORIO FARMAC.ERFO (RK7) cash conversion ratio for how efficiently the company converts equity into cash flow.
LABORATORIO FARMAC.ERFO Market Cap History (2022–2026)
LABORATORIO FARMAC.ERFO market cap history from 2022 to 2026. Data shows change from $14.73 Million to $8.69 Million (-12.85% CAGR). Check today's stock price for LABORATORIO FARMAC.ERFO for real-time trading data and today's change.
LABORATORIO FARMAC.ERFO Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how LABORATORIO FARMAC.ERFO's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore LABORATORIO FARMAC.ERFO (RK7) net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
1.87x
LABORATORIO FARMAC.ERFO's market cap is 1.87 times its annual revenue
Latest Price to Earnings (P/E) Ratio
19.99x
LABORATORIO FARMAC.ERFO's market cap is 19.99 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $14.73 Million | $4.72 Million | $716.07K | 3.12x | 20.57x |
| 2023 | $11.07 Million | $5.93 Million | $553.82K | 1.87x | 19.99x |
Competitor Companies of RK7 by Market Capitalization
Companies near LABORATORIO FARMAC.ERFO in the global market cap rankings as of November 4, 2026. Also see total assets of LABORATORIO FARMAC.ERFO for a full breakdown of the balance sheet.
Key companies related to LABORATORIO FARMAC.ERFO by market ranking:
- Nestlé S.A (F:NESM): Ranked #88 globally with a market cap of $224.33 Billion USD ( €191.89 Billion EUR).
- Nestle S.A. (SW:NESN): Ranked #103 globally with a market cap of $199.45 Billion USD ( CHF157.76 Billion CHF).
- Danone SA (PA:BN): Ranked #543 globally with a market cap of $49.74 Billion USD ( €42.54 Billion EUR).
- Danone SA (F:BSND): Ranked #672 globally with a market cap of $39.61 Billion USD ( €33.88 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #88 | Nestlé S.A | F:NESM | $224.33 Billion | €92.40 |
| #103 | Nestle S.A. | SW:NESN | $199.45 Billion | CHF84.64 |
| #543 | Danone SA | PA:BN | $49.74 Billion | €66.06 |
| #672 | Danone SA | F:BSND | $39.61 Billion | €13.00 |
Market Capitalization of LABORATORIO FARMAC.ERFO (2022–2026)
Market capitalization of LABORATORIO FARMAC.ERFO from 2022 to today. Between 2022 and today, LABORATORIO FARMAC.ERFO's market cap moved from $14.73 Million to $ 8.69 Million, with a yearly change of -12.85%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €8.69 Million | -26.72% |
| 2025 | €11.85 Million | +25.00% |
| 2024 | €9.48 Million | -14.37% |
| 2023 | €11.07 Million | -24.84% |
| 2022 | €14.73 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of LABORATORIO FARMAC.ERFO was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $8.69 Million USD |
| MoneyControl | $8.69 Million USD |
| MarketWatch | $8.69 Million USD |
| marketcap.company | $8.69 Million USD |
| Reuters | $8.69 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About LABORATORIO FARMAC.ERFO
Laboratorio Farmaceutico Erfo S.p.A. engages in the formulation and production of food supplements in Italy. It produces various types of pharmaceutical forms, such as bottles, single-dose vials and bottles, capsules, tablets, and sachets under the Diètnatural and Gianopharma brands, as well as private label brands. The company offers custom formula creation, regulatory advice, graphics, and pack… Read more